Ochratoxin A hapten, ochratoxin A artificial antigen, preparation method of ochratoxin A hapten, kit, and detection method of ochratoxin A
An ochratoxin and artificial antigen technology, applied in the detection of ochratoxin A and the field of ochratoxin A hapten, can solve the problems of low detection limit of thin layer chromatography and expensive equipment, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0028] Preferably, the preparation method of the ochratoxin A artificial antigen described in the embodiments of the present invention comprises:
[0029] pretreatment of the ochratoxin A hapten by an activated ester method; and
[0030] The pretreated ochratoxin A hapten is coupled to the first carrier protein.
[0031] Pretreatment of the ochratoxin A hapten by the activated ester method is to esterify the carboxyl group of the ochratoxin A hapten, further preferably, the ochratoxin A hapten and N-hydroxysuccinimide (NHS) and N,N-dicyclohexylcarbodiimide (DCC) are dissolved in dimethylformamide (DMF) for reaction, and more preferably, 20-40 mg of the ochratoxin A hapten is mixed with 10-20ml of N-hydroxysuccinimide (NHS) and N,N-dicyclohexylcarbodiimide (DCC) were reacted. The above reaction process is carried out under the condition of avoiding light at room temperature and continuously stirring for 10-12 hours. Preferably, the above reaction process is continuously stir...
Embodiment 1
[0052] Preparation of Ochratoxin A Hapten
[0053] Weigh 30mg of ochratoxin A and 15ml p-benzoyl chloride and dissolve in 3ml dimethylformamide (DMF), add triethanolamine at 0°C, react for 1 hour, and quench the reaction with sodium bicarbonate solution It is extracted, dried and concentrated to obtain the ochratoxin A hapten.
Embodiment 2
[0055] Preparation of Artificial Antigen of Ochratoxin A
[0056] Weigh 100 μL of the above ochratoxin A hapten, 10 mg NHS and 20 mg DCC, dissolve in 500 μL dimethylformamide (DMF), and stir at room temperature in the dark for 12 h; Thyroglobulin was added to the 10% N,N-dimethylformamide solution while stirring. After 1 hour, transfer to 0.01M PBS at 4°C for dialysis with magnetic stirring for 2 days, during which the dialysate was changed every 6 hours. When there is no small molecule absorption peak in the dialysate by ultraviolet scanning, it can be centrifuged to obtain the supernatant, which is the ochratoxin A artificial immunogen, and the product is divided into centrifuge tubes and stored at -20°C.
PUM
| Property | Measurement | Unit |
|---|---|---|
| Sensitivity | aaaaa | aaaaa |
| Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


